CMV Vector Expression Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current recombinant protein expression systems fail to achieve high and stable levels of protein production, limiting their application in research and therapeutics.
Innovation Solution
The use of novel nucleic acid vectors incorporating cytomegalovirus (CMV) transcriptional regulatory sequences, including the CMV major immediate early promoter, UTRs, and a post-transcriptional regulatory element (PRE), which provide enhanced expression levels and longevity by stabilizing the expression of recombinant proteins in cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional expression systems are used, then the system structure is simple, but the protein expression level is low
Solution Approach 1:
The patent combines multiple viral regulatory elements (CMV promoter, UTRs, introns, and PRE) into a single integrated expression vector. This merging of functional elements works synergistically to achieve high-level protein expression that none of the individual elements could accomplish alone, directly resolving the contradiction between expression level and vector complexity.
Solution Approach 2:
The expression vector is constructed as a composite of multiple viral genomic components (promoter, 5' UTR, 3' UTR, introns, and post-transcriptional regulatory elements). This composite structure leverages the functional properties of each component to achieve superior expression levels, transforming a simple vector into a high-performance expression system.
2Stability of the object's composition
If conventional expression systems are used, then the vector design is simple, but the expression stability over generations is poor
Solution Approach 1:
The vector design incorporates pre-optimized viral regulatory sequences that have evolved to ensure stable expression. By including elements like the CMV promoter with its inherent stability features and PRE sequences that preemptively maintain expression levels, the system achieves long-term stability without requiring complex external control mechanisms.
Solution Approach 2:
The patent optimizes specific parameters of the regulatory sequences, such as the promoter strength, UTR lengths, and PRE composition, to achieve optimal expression stability. By carefully adjusting these parameters based on viral genome characteristics, the system maintains stable expression over 50+ generations while avoiding unnecessary structural complexity.
3Productivity
If existing expression systems are used, then the system is easy to operate, but the protein production level is insufficient
Solution Approach 1:
The expression vector is divided into functional segments (promoter region, 5' UTR, coding sequence, 3' UTR, PRE) that can be independently optimized and assembled. This segmentation allows for modular construction of the vector, making it easier to manufacture while achieving high protein production levels through the coordinated function of each segment.
4Productivity
If simple promoters are used, then the vector is easier to construct, but the expression level and longevity are limited
Solution Approach 1:
The CMV promoter region is designed to perform multiple functions simultaneously: driving high-level transcription, ensuring proper mRNA processing through UTRs, and maintaining expression stability via PRE sequences. This multi-functionality achieves high expression levels while keeping the promoter region design relatively streamlined compared to using multiple separate elements.
Data Source
AI summary
Disclosed herein are vector systems for expression of polypeptides in eukaryotic cells; and methods of obtaining high-level expression of polypeptides in a eukaryotic cell. Methods and compositions for obtaining stable, long-term expression of recombinant polypeptides are also provided.